DeCure's autonomous Psychiatry AI scientist is researching a drug-repurposing hypothesis for tympanic membrane disease — screening already-approved drugs against its 33-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleTympanic membrane disease maps to a 33-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for tympanic membrane disease is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
nuclear receptor subfamily 3 group C member 2 (NR3C2) — NR3C2 is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet 2,2-difluoro-3-hydroxypropyldrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 4PF3 · 1.1 Å · ligand 6-[1-(2,2-difluoro-3-hydroxypropyl)-5-(4-fluorophenyl)-3-methyl-1H-pyrazol-4-yl]-2H-1,4-benzoxazin-3(4H)-one (HFN). Experimental structure, not a prediction.
What the evidence adds up to
A meta-analysis of paediatric tympanoplasty, covering 30 studies from 1966 to 1997, found that greater success in healing the tympanic membrane after surgery is seen with advancing age. Success was defined as an intact tympanic membrane. None of the other parameters studied — surgical technique, prior adenoidectomy, presence of active infection, size of perforation, status of the contralateral ear, or eustachian tube function — was shown to be a significant predictor of success.
Two case reports from 2007 describe total or near-total breakdown of the tympanic membrane after intratympanic injection of steroids in patients whose ears had been previously irradiated. The authors conclude that tympanic membranes with impaired wound-healing ability, combined with exposure to intratympanic steroids, may be at risk for total or near-total breakdown.
A 2012 case report describes a 68-year-old woman with primary squamous cell carcinoma of the tympanic membrane, an exceptionally rare condition. The lesion was a polypoidal granular nodule confined to the posterior aspect of the tympanic membrane. She underwent lateral temporal bone resection with ipsilateral superficial parotidectomy and selective neck dissection. Post-operative histology confirmed the SCC was confined to the tympanic membrane. The authors state that surgical resection with adjacent structure clearance remains the primary treatment modality.
A 2005 review of caveolin-1 describes it as a coat protein of caveolae involved in protein transport, cholesterol efflux, and regulation of intracellular signalling pathways. No study in this set tests any drug for tympanic membrane repair. What is missing is any randomised trial of a pharmacological intervention for tympanic membrane healing, any investigation of caveolin-1 in tympanic membrane tissue, and any attempt to stratify patients by wound-healing capacity or prior radiation status.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Archives of Otolaryngology - Head and Neck Surgery · 1999 · 172 citations
Meta-analysis of Pediatric Tympanoplasty
AbstractOBJECTIVE: To determine which preoperative conditions or surgical techniques may influence the success of tympanoplasty in the pediatric population. DATA SOURCES: A MEDLINE search of the English-language literature from 1966 to May 1997 was conducted using the search terms pediatric or child and tympanoplasty or myringoplasty. STUDY SELECTION: Articles that provided age-specific data on tympanoplasty or myringoplasty were included. Of the original 651 studies retrieved, 30 were accepted for inclusion. The principal reason for exclusion was inability to separate adult and pediatric results in series that combined both patient populations. DATA EXTRACTION: Success was defined as an intact tympanic membrane for the purpose of this review. Data were tabulated by consensus of 2 reviewers. DATA SYNTHESIS: The effect of surgical technique, prior adenoidectomy, presence of active infection, size of perforation, status of the contralateral ear, age, and eustachian tube function on healing of the tympanic membrane after surgery was assessed. Only those studies providing data on a given parameter of interest could be included when comparing each variable. Weighted means were compared and subjected to sensitivity analysis. Simple linear regression analysis was used to assess the effect of age on outcome. CONCLUSIONS: Greater success in healing of the tympanic membrane following tympanoplasty in children is seen with advancing age. None of the other parameters studied was shown to be a significant predictor of success. Guidelines for reporting results of tympanoplasty are presented.
Tympanic Membrane Breakdown After Intratympanic Injection of Steroids in Irradiated Ears
AbstractOBJECTIVE: To describe a rare complication of intratympanic injection of steroids in susceptible ears. PATIENTS: We present two patients with a history of irradiation involving the injected ear. INTERVENTION: Therapeutic. MAIN OUTCOME MEASURE: Tympanic membrane condition after intratympanic injection of steroids. RESULTS: Total or near-total breakdown of the irradiated tympanic membrane. CONCLUSION: Tympanic membranes with an impaired wound-healing ability, together with exposure to intratympanic steroids, may be at risk for total or near-total breakdown.
AbstractCaveolin-1 was first identified as an approximately 22-kDa tyrosine-phosphorylated protein in Rous sarcoma virus-transformed cells (Glenney, 1989; Glenney and Soppet, 1992). Caveolin-1 has subsequently attracted much attention because it serves as a major coat protein of caveolae (Rothberg, et al., 1992; Smart, et al., 1999). The caveolar membrane system, comprising plasma membrane invaginations and juxtamembrane uncoated vesicles, mediates certain protein transport processes, including transcytosis, potocytosis, and clathrin-independent endocytosis (Anderson, 1998). Caveolin-1 and caveolae are also involved in mediating cellular cholesterol efflux (Smart et al., 1999; Fielding and Fielding, 2001), and a large body of evidence implicates caveolin-1 in regulating intracellular signaling pathways.
International Journal of Surgery Case Reports · 2012 · 2 citations · open access
Isolated primary squamous cell carcinoma of the tympanic membrane
AbstractINTRODUCTION: Primary squamous cell carcinoma (SCC) of the tympanic membrane is exceptionally rare. We describe the history, investigation and management of this disease. PRESENTATION OF CASE: A 68-year-old woman presented with a three month history of intermittent otorrhoea and external ear canal (EAC) pruritus. Otoscopy revealed a polypoidal granular nodule, confined to the posterior aspect of the tympanic membrane. Examination under anaesthesia (EUA) confirmed that the lesion was confined to the tympanic membrane, with a surrounding rim of normal drum. Biopsies were consistent with well differentiated SCC. DISCUSSION: Following discussion at multi-disciplinary team meeting for treatment planning, the patient underwent lateral temporal bone resection with ipsilateral superficial parotidectomy and selective neck dissection. Post-operative histology confirmed an SCC confined to the tympanic membrane. CONCLUSION: SCC of the tympanic membrane is an extremely rare condition. As with early temporal bone SCC, surgical resection with adjacent structure clearance remains the primary treatment modality.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
